WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that Company management will present at the Lazard Capital Markets 7th Annual Healthcare Conference at 3:15 p.m. ET on November 17, 2010. A live webcast of the presentation can be accessed through the “Investor Information” section of the Company’s website, www.immunogen.com; a replay of the presentation will be available at the same location for one week.
